Cargando…

Development of a Microfluidic Array to Study Drug Response in Breast Cancer

Luminal geometries are common structures in biology, which are challenging to mimic using conventional in vitro techniques based on the use of Petri dishes. In this context, microfluidic systems can mimic the lumen geometry, enabling a large variety of studies. However, most microfluidic models stil...

Descripción completa

Detalles Bibliográficos
Autores principales: Virumbrales-Muñoz, María, Livingston, Megan K., Farooqui, Mehtab, Skala, Melissa C., Beebe, David J., Ayuso, Jose M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930663/
https://www.ncbi.nlm.nih.gov/pubmed/31801265
http://dx.doi.org/10.3390/molecules24234385
_version_ 1783482945117356032
author Virumbrales-Muñoz, María
Livingston, Megan K.
Farooqui, Mehtab
Skala, Melissa C.
Beebe, David J.
Ayuso, Jose M.
author_facet Virumbrales-Muñoz, María
Livingston, Megan K.
Farooqui, Mehtab
Skala, Melissa C.
Beebe, David J.
Ayuso, Jose M.
author_sort Virumbrales-Muñoz, María
collection PubMed
description Luminal geometries are common structures in biology, which are challenging to mimic using conventional in vitro techniques based on the use of Petri dishes. In this context, microfluidic systems can mimic the lumen geometry, enabling a large variety of studies. However, most microfluidic models still rely on polydimethylsiloxane (PDMS), a material that is not amenable for high-throughput fabrication and presents some limitations compared with other materials such as polystyrene. Thus, we have developed a microfluidic device array to generate multiple bio-relevant luminal structures utilizing polystyrene and micro-milling. This platform offers a scalable alternative to conventional microfluidic devices designed in PDMS. Additionally, the use of polystyrene has well described advantages, such as lower permeability to hydrophobic molecules compared with PDMS, while maintaining excellent viability and optical properties. Breast cancer cells cultured in the devices exhibited high cell viability similar to PDMS-based microdevices. Further, co-culture experiments with different breast cell types showed the potential of the model to study breast cancer invasion. Finally, we demonstrated the potential of the microfluidic array for drug screening, testing chemotherapy drugs and photodynamic therapy agents for breast cancer.
format Online
Article
Text
id pubmed-6930663
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69306632019-12-26 Development of a Microfluidic Array to Study Drug Response in Breast Cancer Virumbrales-Muñoz, María Livingston, Megan K. Farooqui, Mehtab Skala, Melissa C. Beebe, David J. Ayuso, Jose M. Molecules Article Luminal geometries are common structures in biology, which are challenging to mimic using conventional in vitro techniques based on the use of Petri dishes. In this context, microfluidic systems can mimic the lumen geometry, enabling a large variety of studies. However, most microfluidic models still rely on polydimethylsiloxane (PDMS), a material that is not amenable for high-throughput fabrication and presents some limitations compared with other materials such as polystyrene. Thus, we have developed a microfluidic device array to generate multiple bio-relevant luminal structures utilizing polystyrene and micro-milling. This platform offers a scalable alternative to conventional microfluidic devices designed in PDMS. Additionally, the use of polystyrene has well described advantages, such as lower permeability to hydrophobic molecules compared with PDMS, while maintaining excellent viability and optical properties. Breast cancer cells cultured in the devices exhibited high cell viability similar to PDMS-based microdevices. Further, co-culture experiments with different breast cell types showed the potential of the model to study breast cancer invasion. Finally, we demonstrated the potential of the microfluidic array for drug screening, testing chemotherapy drugs and photodynamic therapy agents for breast cancer. MDPI 2019-11-30 /pmc/articles/PMC6930663/ /pubmed/31801265 http://dx.doi.org/10.3390/molecules24234385 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Virumbrales-Muñoz, María
Livingston, Megan K.
Farooqui, Mehtab
Skala, Melissa C.
Beebe, David J.
Ayuso, Jose M.
Development of a Microfluidic Array to Study Drug Response in Breast Cancer
title Development of a Microfluidic Array to Study Drug Response in Breast Cancer
title_full Development of a Microfluidic Array to Study Drug Response in Breast Cancer
title_fullStr Development of a Microfluidic Array to Study Drug Response in Breast Cancer
title_full_unstemmed Development of a Microfluidic Array to Study Drug Response in Breast Cancer
title_short Development of a Microfluidic Array to Study Drug Response in Breast Cancer
title_sort development of a microfluidic array to study drug response in breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930663/
https://www.ncbi.nlm.nih.gov/pubmed/31801265
http://dx.doi.org/10.3390/molecules24234385
work_keys_str_mv AT virumbralesmunozmaria developmentofamicrofluidicarraytostudydrugresponseinbreastcancer
AT livingstonmegank developmentofamicrofluidicarraytostudydrugresponseinbreastcancer
AT farooquimehtab developmentofamicrofluidicarraytostudydrugresponseinbreastcancer
AT skalamelissac developmentofamicrofluidicarraytostudydrugresponseinbreastcancer
AT beebedavidj developmentofamicrofluidicarraytostudydrugresponseinbreastcancer
AT ayusojosem developmentofamicrofluidicarraytostudydrugresponseinbreastcancer